About the Authors
- Denis Collins
-
* E-mail: denis.collins@dcu.ie (DC); martin.weisser@roche.com (MW)
Affiliation National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland
- Wolfgang Jacob
-
Affiliation Roche Innovation Center Munich, Penzberg, Germany
- Juan Miguel Cejalvo
-
Affiliation Department of Medical Oncology, Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain
- Maurizio Ceppi
-
Affiliation Roche Innovation Center Munich, Penzberg, Germany
- Ian James
-
Affiliation A4P Consulting Ltd, Sandwich, United Kingdom
- Max Hasmann
-
Affiliation Roche Innovation Center Munich, Penzberg, Germany
- John Crown
-
Affiliations National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland, Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland
- Andrés Cervantes
-
Affiliation Department of Medical Oncology, Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain
- Martin Weisser
-
* E-mail: denis.collins@dcu.ie (DC); martin.weisser@roche.com (MW)
Affiliation Roche Innovation Center Munich, Penzberg, Germany
- Birgit Bossenmaier
-
Affiliation Roche Innovation Center Munich, Penzberg, Germany
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: WJ, MC, MH, MW, BB are employees of Roche Penzberg, Germany and WJ, MH and MW have ownership of stocks or shares in Roche. DC has received research grants and travel grants and honoraria for speaking or participation at meetings from Roche. JC has received research grants from Roche. IJ is an employee of A4P Consulting Ltd. and was involved in the collection of biomarker data in the study; Roche Diagnostics funded this consultancy role. JMC and AC declare no conflicts of interest.
Author Contributions
Conceptualization: MC MH MW BB. Data curation: DC WJ JMC. Formal analysis: DC WJ JMC. Funding acquisition: MH. Investigation: DC JMC AC MW BB. Methodology: DC JMC. Project administration: MW. Resources: DC JMC MC IJ JC AC BB. Supervision: JC MW BB. Validation: DC JMC JC AC MW BB. Visualization: DC WJ BB. Writing – original draft: DC WJ BB. Writing – review & editing: DC WJ JMC MC IJ MH JC AC MW BB.